CS logo
small CS logo
Kern Research Inc.

Bakersfield, California, United States
Research institute in Bakersfield, California
1921 18th St, Bakersfield, CA 93301

About Kern Research Inc.


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Concert Pharmaceuticals
3
Optinose US Inc.
2
Total Rows: 9

Clinical Trials at Kern Research Inc.


During the past decade, Kern Research Inc. conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 3 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22552211220000001122Started TrialsCompleted Trails201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps
2018-12-31
2023-12-01
Recruiting
120
Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis With or Without the Presence of Nasal Polyps
2018-11-27
2022-01-19
Completed
332
A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis
2019-06-27
2020-11-26
Completed
179
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
2019-04-04
2024-05-01
Enrolling by invitation
1,000
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MTPS9579A in Patients With Asthma Requiring Inhaled Corticosteroids and a Second Controller
2019-10-31
2022-05-19
Completed
135
House Dust Mite Allergy Trial In Children
2019-10-12
2023-04-01
Active, not recruiting
1,459
A Study of LY3454738 in Adults With Chronic Spontaneous Urticaria
2019-11-15
2021-02-24
Terminated
52
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
2020-09-08
2021-04-13
Completed
122

Rows per page:

1–12 of 12

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Kern Research Inc." #1 sponsor was "Concert Pharmaceuticals" with 3 trials, followed by "Optinose US Inc." with 2 trials sponsored, "ALK-Abelló A/S" with 1 trials sponsored, "Bond Avillion 2 Development LP" with 1 trials sponsored and "Bosch Healthcare Solutions GmbH" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kern Research Inc." #1 collaborator was "Global BioClinical" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsConcert Pharmaceuticals: 3Concert Pharmaceuticals: 3Optinose US Inc.: 2Optinose US Inc.: 2ALK-Abelló A/S: 1ALK-Abelló A/S: 1Bond Avillion 2Development LP: 1Bond Avillion 2Development LP: 1Bosch HealthcareSolutions GmbH: 1Bosch HealthcareSolutions GmbH: 1Celldex Therapeutics: 1Celldex Therapeutics: 1Eli Lilly and Company: 1Eli Lilly and Company: 1Genentech, Inc.: 1Genentech, Inc.: 1Pfizer: 1Pfizer: 1

Created with Highcharts 11.1.0Top CollaboratorsGlobal BioClinical: 1Global BioClinical: 1Parexel: 1Parexel: 1

Clinical Trials Conditions at Kern Research Inc.


According to Clinical.Site data, the most researched conditions in "Kern Research Inc." are "Alopecia Areata" (3 trials), "Asthma" (3 trials), "Chronic Spontaneous Urticaria" (2 trials), "Allergic Rhinitis Due to Dermatophagoides Farinae" (1 trials) and "Allergic Rhinitis Due to Dermatophagoides Pteronyssinus" (1 trials). Many other conditions were trialed in "Kern Research Inc." in a lesser frequency.

Clinical Trials Intervention Types at Kern Research Inc.


Most popular intervention types in "Kern Research Inc." are "Drug" (10 trials), "Biological" (2 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "CTP-543" (2 trials), "OPN-375" (2 trials), "AS MDI" (1 trials) and "BDA MDI" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Kern Research Inc.


The vast majority of trials in "Kern Research Inc." are 12 trials for "All" genders.

Clinical Trials Status at Kern Research Inc.


Currently, there are NaN active trials in "Kern Research Inc.". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 5 completed trials in Kern Research Inc., undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Kern Research Inc., 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 6Phase 2: 6Phase 3: 6Phase 3: 6Not Applicable: 1Not Applicable: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 5Completed: 5Recruiting: 3Recruiting: 3Active, not recruiting: 2Active, not recruiting: 2Enrolling by invitation: 1Enrolling by invitation: 1Terminated: 1Terminated: 1